Global Injectable Drug Delivery Market Report Segmented by Device Type (Conventional & Self-Injectables, Needle-free Injectors), Route of Administration (Intravenous, Subcutaneous, Intramuscular), Therapeutic Application, Formulation Packaging, Forecast to 2031

Request Quote Download FREE Sample
Single User

Table of Contents

  1. Introduction
    • Introduction
    • Market Scope
      • Market Definition
      • Segments Covered
      • Regional Segmentation
    • Research Timeframe
    • Currency Considered
    • Study Limitations
    • Stakeholders
    • List of Abbreviations
    • Key Conferences and Events (2026-2027)
  2. Research Methodology
    • Secondary Research
    • Primary Research
    • Market Estimation
      • Bottom-Up Approach
      • Top-Down Approach
    • Market Forecasting
  3. Executive Summary
    • Injectable Drug Delivery Marke"4">
    • Market Overview
      • Market Dynamics
        • Drivers
          • Growing demand for biologics and biosimilars
          • Increasing prevalence of chronic diseases requiring injectables
          • Expansion of global immunization programs
          • Global aging population requiring long-term care
          • Innovations in smart injectors and wearable devices
          • Shift towards self-administration and home-based care
        • Restraints
          • Risk of needle-stick injuries
          • High cost of advanced injectors
          • Stringent regulatory and compliance requirements
        • Opportunities
          • Development of needle-free and micro-needle systems
          • Growing adoption of wearable injectors for high-viscosity biologics
          • Shift towards long-acting and biodegradable formulations
          • Rising use of prefilled & ready-to-administer formats for safety & speed
        • Key Market Trends
          • Shift towd drug delivery devices
          • Growth of on-body, large-volume injectors for specialty drugs
        • Unmet Market Needs
        • Industry Speaks
    • "5">
    • Global Injectable Drug Delivery Market Size & Forecast (2024-2031), By Device Type, USD Million
      • Introduction
      • Conventional Injectables
      • Self-injectables
      • Needle-free Injectors
      • Wearable Injectors
      • Others
  • Global Injectable Drug Delivery Market Size & Forecast (2024-2031), By Route of Administration, USD Million
    • Introduction
    • Subcutaneous
    • Intravenous
    • Intramuscular
    • Others
  • Global Injectable Drug Delivery Market Size & Forecast (2024-2031), By Therapeutic Application, USD Million
    • Introduction
    • Oncology
    • Autoimmune Diseases
    • Hormonal Disorders
    • Others
  • Global Injectable Drug Delivery Market Size & Forecast (2024-2031), By Formulation Packaging, USD Million
    • Introduction
    • Vials
    • Ampoules
    • Bottles
    • Cartridges
    • Others
  • Global Injectable Drug Delivery Market Size & Forecast (2024-2031), By End-user, USD Million
    • Introduction
    • Hospitals
    • Specialty Clinics
    • ASCs
    • Home-care Settings
    • Others
  • Global Injectable Drug Delivery Market Size & Forecast (2024-2031), By Region, USD Million
    • Introduction
    • North America Injectable Drug Delivery Market Size & Forecast (2024-2031), By Country, USD Million
      • US
        • Market Size & Forecast, By Device Type (USD Million)
        • Market Size & Forecast, By Route of Administration (USD Million)
        • Market Size & Forecast, By Therapeutic Application (USD Million)
        • Market Size & Forecast, By Formulation Packaging (USD Million)
        • Market Size & Forecast, By End-user (USD Million)
      • Canada
        • Market Size & Forecast, By Device Type (USD Million)
        • Market Size & Forecast, By Route of Administration (USD Million)
        • Market Size & Forecast, By Therapeutic Application (USD Million)
        • Market Size & Forecast, By Formulation Packaging (USD Million)
        • M>
    • Europe Injectable Drug Delivery Market Size & Forecast (2024-2031), By Country, USD Million
      • UK
        • Market Size & Forecast, By Device Type (USD Million)
        • Market Size & Forecast, By Route of Administration (USD Million)
        • Market Size & Forecast, By Therapeutic Application (USD Million)
        • Market Size & Forecast, By Formulation Packaging (USD Million)
        • Market Size & Forecast, By End-user (USD Million)
      • Germany
        • Market Size & Forecast, By Device Type (USD Million)
        • Market Size & Forecast, By Route of Administration (USD Million)
        • Market Size & Forecast, By Therapeutic Application (USD Million)
        • Market Size & Forecast, By Formulation Packaging (USD Million)
        • Market Size & Forecast, By End-user (USD Million)
      • France
        • Market Size & Forecast, By Device Typeast, By Route of Administration (USD Million)
        • Market Size & Forecast, By Therapeutic Application (USD Million)
        • Market Size & Forecast, By Formulation Packaging (USD Million)
        • Market Size & Forecast, By End-user (USD Million)
      • Italy
        • Market Size & Forecast, By Device Type (USD Million)
        • Market Size & Forecast, By Route of Administration (USD Million)
        • Market Size & Forecast, By Therapeutic Application (USD Million)
        • Market Size & Forecast, By Formulation Packaging (USD Million)
        • Market Size & Forecast, By End-user (USD Million)
      • Spain
        • Market Size & Forecast, By Device Type (USD Million)
        • Market Size & Forecast, By Route of Administration (USD Million)
        • Market Size & Forecast, By Therapeutic Application (USD Million)
        • Market Size & Forecast, By Formulation Packaging (USD Million)
        • Ma-user (USD Million)
      • Rest of Europe
        • Market Size & Forecast, By Device Type (USD Million)
        • Market Size & Forecast, By Route of Administration (USD Million)
        • Market Size & Forecast, By Therapeutic Application (USD Million)
        • Market Size & Forecast, By Formulation Packaging (USD Million)
        • Market Size & Forecast, By End-user (USD Million)
    • Asia Pacific (APAC) Injectable Drug Delivery Market Size & Forecast (2024-2031), By Country, USD Million
      • China
        • Market Size & Forecast, By Device Type (USD Million)
        • Market Size & Forecast, By Route of Administration (USD Million)
        • Market Size & Forecast, By Therapeutic Application (USD Million)
        • Market Size & Forecast, By Formulation Packaging (USD Million)
        • Market Size & Forecast, By End-user (USD Million)
      • Japan (USD Million)
      • Market Size & Forecast, By Route of Administration (USD Million)
      • Market Size & Forecast, By Therapeutic Application (USD Million)
      • Market Size & Forecast, By Formulation Packaging (USD Million)
      • Market Size & Forecast, By End-user (USD Million)
    • India
      • Market Size & Forecast, By Device Type (USD Million)
      • Market Size & Forecast, By Route of Administration (USD Million)
      • Market Size & Forecast, By Therapeutic Application (USD Million)
      • Market Size & Forecast, By Formulation Packaging (USD Million)
      • Market Size & Forecast, By End-user (USD Million)
    • Rest of Asia Pacific
      • Market Size & Forecast, By Device Type (USD Million)
      • Market Size & Forecast, By Route of Administration (USD Million)
      • Market Size & Forecast, By Therapeutic Application (USD Million)
      • Market Size & Forecast, By End-user (USD Million)
  • Latin America (LATAM) Injectable Drug Delivery Market Size & Forecast (2024-2031), USD Million
    • Market Size & Forecast, By Device Type (USD Million)
    • Market Size & Forecast, By Route of Administration (USD Million)
    • Market Size & Forecast, By Therapeutic Application (USD Million)
    • Market Size & Forecast, By Formulation Packaging (USD Million)
    • Market Size & Forecast, By End-user (USD Million)
  • Middle East & Africa (MEA) Injectable Drug Delivery Market Size & Forecast (2024-2031), USD Million
    • Market Size & Forecast, By Device Type (USD Million)
    • Market Size & Forecast, By Route of Administration (USD Million)
    • Market Size & Forecast, By Therapeutic Application (USD Million)
    • Market Size & Forecast, By Formulation Size & Forecast, By End-user (USD Million)
    1. Competitive Landscape
      • Key Players and their Competitive Positioning
        • Key Player Comparison
        • Segment-wise Player Mapping
        • Market Share Analysis (2025)
        • Company Categorization Matrix
          • Dominants/Leaders
          • New Entrants
          • Emerging Players
          • Innovative Players
        • Key Strategies Assessment, By Player (2023-2025)
          • New Product Launches
          • Partnerships, Agreements, & Collaborations
          • Mergers & Acquisitions
          • Geographic Expansion
    1. Company Profiles*

    (Business Overview, Financial Performance**, Products Offered, Recent Developments)

    • Becton, Dickinson and Company
    • Medtronic plc
    • Stryker Corporation
    • Halozyme Therapeutics, Inc. (Antares Pharma, Inc.)
    • Gerresheimer AG
    • Schott AG
    • Braun Melsungen AG
    • Stevanato Group S.p.A.
    • Amgen Inc.
    • Pfizer Inc.
    • Other Prominent Players

    Note: *Indicative list

    **For listed companies